If this message is not displayed correctly, click here.

NDT-Edu@ENP Logo

 

FOR KIDNEY & BLOOD
PRESSURE RELATED
DISORDERS

Facebook Twitter LinkedIn

An official publication of

ERA-EDTA Logo

NDT-Educational@ENP Newsletter

Issue 5 - April 2019

EDITOR IN CHIEF: Davide Bolignano

EDITORIAL BOARD: click here for the complete list

NEWSLETTER DESIGN: Francesca Trebelli

Summary Reports from 55th ERA-EDTA Congress

From the RNA world to the clinic: RNAs as drugs and drug targets

Presented by Bruce A. Sullenger

Summary1

During the past 25 years, the idea of using RNA molecules as therapeutic agents has evolved from a concept into a clinical reality. The structural and functional versatility of RNA molecules has inspired translational and clinical researchers to explore the utility of RNA-based therapeutic agents for a wide variety of medical applications including renal disorders.

READ MORE

Congress Presentation

This talk has been presented by Bruce A. Sullenger during the 55th ERA-EDTA Congress in Copenhagen, Denmark.

View it here
Jayne

Continuous renal replacement therapy

Presented by Esteban Poch

Summary2

Acute kidney injury (AKI) requiring a renal-replacement (RRT) therapy affects more than 13% of intensive care units (ICU) patients. During the past decade, the incidence of RRT-requiring AKI almost doubled worldwide and the mortality of the patients remained as high as 50%. The most common modalities are continuous RRT (CRRT) (75.2%), followed by intermittent hemodialysis (IHD) (24.1%) and peritoneal dialysis (0.7%).

READ MORE

   Congress Presentation

This talk has been presented by Esteban Poch during the 55th ERA-EDTA Congress in Copenhagen, Denmark.

View it here
Wanner

References

Read this selection of articles about the two summary report fields.

Read the articles
Journals

New ERA-EDTA Dialogues!

Image

Predicting outcomes in ANCA-associated GN: your “real-life” experience

by Francesco Pesce

Join the dialogue

Managing heart failure along with moderate-severe chronic kidney disease. Which is the best treatment choice?

by Evangelia Ntounousi

Join the dialogue
Dialogue
Image

Long-term graft survival in deceased kidney donors: how much importance should we give to HLA matching?

by Ana Carina Ferreira

Join the dialogue

 Last weeks to comment these ERA-EDTA Dialogues!

Dialogue

Strawberries always fill my heart with joy (...and my kidneys with potassium): a clinical case study

by Björn Meijers

Join the dialogue

Potassium intake in CKD patients. Are we prescribing too much? Or too little? What is your taking?

by Pietro Manuel Ferraro

Join the dialogue
Dialogue
Dialogue

Incremental Dialysis: from (limited) evidence to daily practice

by Kusztal Mariusz

Join the dialogue

FOLLOW US

Facebook Twitter LinkedIn Instagram Web Site E-Mail
Contact us
Unsubscribe

The ERA-EDTA collects and processes personal information to provide you with details regarding the Association and its activities. The information is used for accounting and commercial purposes by ERA-EDTA and/or Euromeetings s.r.l. in compliance with the EU General Data Protection Regulation (2016/679).